Psychiatric Services
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by El-Mallakh, R. S.
* Articles by Karippot, A.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by El-Mallakh, R. S.
* Articles by Karippot, A.
Related Collections
* Bipolar Disorder
* Depression
* Antidepressants
Psychiatr Serv 53:580-584, May 2002
© 2002 American Psychiatric Association


Other Articles

Use of Antidepressants to Treat Depression in Bipolar Disorder

Rif S. El-Mallakh, M.D. and Anoop Karippot, M.D.

For decades, clinicians and researchers did not distinguish between bipolar and unipolar depression. The safety and efficacy of antidepressants for the treatment of unipolar depression were studied, and the data were applied to the treatment of bipolar depression without validation. As evidence has accumulated that antidepressants may adversely affect the course of bipolar illness, more research has been focused on that problem. Current evidence suggests that although antidepressants are clearly effective in the acute treatment of type I and type II bipolar depression, they are also associated with a variety of adverse outcomes. They may induce a switch to mania or hypomania at a rate two or three times the spontaneous rate. Long-term use may destabilize the illness, leading to an increase in the number of both manic and depressed episodes; induce rapid cycling (at least four episodes a year); and increase the likelihood of a mixed state. Antidepressants should be used with caution in the treatment of bipolar depression.




This article has been cited by other articles:


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
R. L. Tamas, D. Menkes, and R. S. El-Mallakh
Stimulating Research: A Prospective, Randomized, Double-Blind, Sham-Controlled Study of Slow Transcranial Magnetic Stimulation in Depressed Bipolar Patients
J Neuropsychiatry Clin Neurosci, May 1, 2007; 19(2): 198 - 199.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Q. Wei, X.-Y. Lu, L. Liu, G. Schafer, K.-R. Shieh, S. Burke, T. E. Robinson, S. J. Watson, A. F. Seasholtz, and H. Akil
Glucocorticoid receptor overexpression in forebrain: A mouse model of increased emotional lability
PNAS, August 10, 2004; 101(32): 11851 - 11856.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2002 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org